Search

Your search keyword '"Gohrbandt B"' showing total 121 results
Start Over Author "Gohrbandt B"
121 results on '"Gohrbandt B"'

5. Lebensqualität und psychosoziale Rehabilitation bei Lungenkrebsüberlebenden (LARIS) – eine multizentrische Studie

Author

Hechtner, M, additional, Eichler, M, additional, Wehler, B, additional, Buhl, R, additional, Stratmann, J, additional, Sebastian, M, additional, Schmidberger, H, additional, Gohrbandt, B, additional, Peuser, J, additional, Kortsik, C, additional, Nestle, U, additional, Wiesemann, S, additional, Wirtz, H, additional, Wehler, T, additional, Bals, R, additional, Blettner, M, additional, and Singer, S, additional

Published
2017
Full Text
View/download PDF

8. Evolving Risk Factors for Mortality after Lung Transplantation over the Last 10 Years: Insights from a Single-Centre Database

Author

Ius, F., primary, Mehwald-Goeke, M., additional, Sommer, W., additional, Verboom, M., additional, Erdfelder, C., additional, Tudorache, I., additional, Kuehn, C., additional, Avsar, M., additional, Salman, J., additional, Siemeni, T., additional, Boethig, D., additional, Greer, M., additional, Gohrbandt, B., additional, Schwerk, N., additional, Gottlieb, J., additional, Welte, T., additional, Haverich, A., additional, and Warnecke, G., additional

Published
2016
Full Text
View/download PDF

9. S3-Guideline: Use of intra aortic Counterpulsation in Cardiac Surgery

Author

Pilarczyk, K., Bauer, A., Boening, A., von der Brelie, M., Eichler, I., Gohrbandt, B., Groesdonk, H. V., Haake, N., Heringlake, M., Langebartels, G., Marggraf, G., Markewitz, A., Thiele, H., Trummer, G., Pilarczyk, K., Bauer, A., Boening, A., von der Brelie, M., Eichler, I., Gohrbandt, B., Groesdonk, H. V., Haake, N., Heringlake, M., Langebartels, G., Marggraf, G., Markewitz, A., Thiele, H., and Trummer, G.

Published
2015

10. Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) - short version

Author

Baron, R, Binder, A, Biniek, R, Braune, S, Buerkle, H, Dall, P, Demirakca, S, Eckardt, R, Eggers, V, Eichler, I, Fietze, I, Freys, S, Fründ, A, Garten, L, Gohrbandt, B, Harth, I, Hartl, W, Heppner, HJ, Horter, J, Huth, R, Janssens, U, Jungk, C, Kaeuper, KM, Kessler, P, Kleinschmidt, S, Kochanek, M, Kumpf, M, Meiser, A, Mueller, A, Orth, M, Putensen, C, Roth, B, Schaefer, M, Schaefers, R, Schellongowski, P, Schindler, M, Schmitt, R, Scholz, J, Schroeder, S, Schwarzmann, G, Spies, C, Stingele, R, Tonner, P, Trieschmann, U, Tryba, M, Wappler, F, Waydhas, C, Weiss, B, Weisshaar, G, DAS-Taskforce 2015, Baron, R, Binder, A, Biniek, R, Braune, S, Buerkle, H, Dall, P, Demirakca, S, Eckardt, R, Eggers, V, Eichler, I, Fietze, I, Freys, S, Fründ, A, Garten, L, Gohrbandt, B, Harth, I, Hartl, W, Heppner, HJ, Horter, J, Huth, R, Janssens, U, Jungk, C, Kaeuper, KM, Kessler, P, Kleinschmidt, S, Kochanek, M, Kumpf, M, Meiser, A, Mueller, A, Orth, M, Putensen, C, Roth, B, Schaefer, M, Schaefers, R, Schellongowski, P, Schindler, M, Schmitt, R, Scholz, J, Schroeder, S, Schwarzmann, G, Spies, C, Stingele, R, Tonner, P, Trieschmann, U, Tryba, M, Wappler, F, Waydhas, C, Weiss, B, Weisshaar, G, and DAS-Taskforce 2015

Abstract

In 2010, under the guidance of the DGAI (German Society of Anaesthesiology and Intensive Care Medicine) and DIVI (German Interdisciplinary Association for Intensive Care and Emergency Medicine), twelve German medical societies published the "Evidence- and Consensus-based Guidelines on the Management of Analgesia, Sedation and Delirium in Intensive Care". Since then, several new studies and publications have considerably increased the body of evidence, including the new recommendations from the American College of Critical Care Medicine (ACCM) in conjunction with Society of Critical Care Medicine (SCCM) and American Society of Health-System Pharmacists (ASHP) from 2013. For this update, a major restructuring and extension of the guidelines were needed in order to cover new aspects of treatment, such as sleep and anxiety management. The literature was systematically searched and evaluated using the criteria of the Oxford Center of Evidence Based Medicine. The body of evidence used to formulate these recommendations was reviewed and approved by representatives of 17 national societies. Three grades of recommendation were used as follows: Grade "A" (strong recommendation), Grade "B" (recommendation) and Grade "0" (open recommendation). The result is a comprehensive, interdisciplinary, evidence and consensus-based set of level 3 guidelines. This publication was designed for all ICU professionals, and takes into account all critically ill patient populations. It represents a guide to symptom-oriented prevention, diagnosis, and treatment of delirium, anxiety, stress, and protocol-based analgesia, sedation, and sleep-management in intensive care medicine., Die vorherige Version der S3-Leitlinie "Analgesie, Sedierung und Delirmanagement in der Intensivmedizin" wurde 2010 unter der Federführung der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI) und der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin (DIVI) publiziert. Neue Evidenz aus Studien ebenso wie neue Leitlinien, u.a. die 2013 erschienene Leitlinie der U.S.-amerikanischen Society of Critical Care Medicine (SCCM), des American College of Critical Care Medicine (ACCM) und der American Society of Health-System Pharmacists (ASHP), gaben nicht nur Anlass zu einem Update der deutschen Empfehlungen von 2010. Für die Fortschreibung der S3-Leitlinie wurden eine Neuformulierung von klinisch relevanten Schlüsselfragen und die signifikante Erweiterung der Leitlinie um neue Facetten der Behandlung, wie zum Beispiel das Schlafmanagement, notwendig. Dazu wurde die systematisch gesuchte Literatur nach Kriterien des Oxford Centre of Evidence Based Medicine bewertet. Der enorme Evidenzkörper bildete die Grundlage für die Empfehlungen, die von Mandatsträgern aus 17 Fachgesellschaften konsentiert wurden. In den Empfehlungen wurden die Grade "A" (starke Empfehlung), "B" (Empfehlung) und "0" (offene Empfehlung) gewählt. Als Ergebnis dieses Prozesses liegt nun die weltweit umfassendste, interdisziplinär erarbeitete evidenz- und konsensbasierte Stufe 3 Leitlinie vor. Die Leitlinie richtet sich an alle auf der Intensivstation tätigen Berufsgruppen, die Empfehlungen berücksichtigen alle intensivmedizinisch-behandelten Patientengruppen. Sie stellt einen Leitfaden zur symptomorientierten Prävention, Diagnostik und Therapie von Delir, Angst, Stress und der protokollbasierten Analgesie, Sedierung und dem Schlafmanagement in der Intensivmedizin für Erwachsene und Kinder dar.

Published
2015

12. Warm or cold ischemia in animal models of lung ischemia-reperfusion injury

Author

Warnecke, G., Sommer, S.P., Gohrbandt, B., Fischer, S., Hohlfeld, J.M., Niedermeyer, J., Haverich, A., Struber, M., and Publica

Subjects
Transplantation, Ischemia, animal model, ischemia-reperfusion injury, LPD solution
Abstract

Objective: Experiments were designed to compare large animal models for lung ischemia-reperfusion injury using either 90 minutes' warm or 24 hours' cold ischemia. Methods: In 6 pigs, the left lung was perfused in situ with cold LPD solution. Reperfusion was started after 90 min of warm ischemia. The left lung of 6 donor pigs was perfused with LPD solution and the lung transplanted after 24 hours of cold storage into 6 recipient pigs. In both groups the right pulmonary artery and main bronchus were clamped after reperfusion of the left lung. Bronchoalveolar lavage (BAL) was obtained before ischemia and after 2 h of reperfusion. Hemodynamic and respiratory parameters were monitored. Surfactant activity was determined from the BAL in a pulsating bubble surfactometer. Results: Moderate lung injury was evident after reperfusion, but without any significant differences between groups. Surfactant composition and function were mildly impaired after reperfusion in both groups. Conclusions: Our results suggest that short periods of warm ischemia might be accepted as an accelerated model for ischemia-reperfusion injury of the lung after cold storage.

Published
2004

14. Early biochemical indicators of the obliterative bronchiolitis syndrome in lung transplantation

Author

Hausen B, Dwenger A, Gohrbandt B, Niedermeyer J, Zink C, Stefanos Demertzis, and Hj, Schäfers

Subjects
Graft Rejection, Male, Pancreatic Elastase, Neutrophils, Zymosan, Middle Aged, Opportunistic Infections, Opsonin Proteins, Leukocyte Count, Risk Factors, Virus Diseases, Acetylglucosaminidase, Luminescent Measurements, Pneumonia, Bacterial, Humans, Female, Luminol, Prospective Studies, Bronchiolitis Obliterans, Lung Transplantation
Abstract

The diagnosis of the obliterative bronchiolitis syndrome in lung transplantation is presently best established by evaluation of postoperative lung function tests. Unfortunately the decline in lung function occurs only when obliteration has progressed significantly and is therefore not an early predictive indicator. To distinguish patients at increased risk for the development of obliterative bronchiolitis, we regularly assessed the chemiluminescence response of polymorphonuclear leukocytes, opsonic capacity, and plasma elastase/beta-N-acetylglucosaminidase in 52 outpatients (25 women and 27 men; mean age 45 +/- 12 years) who underwent transplantation between January 1991 and January 1992. Recent onset bronchiolitis within the described observation period occurred in 16 patients (group obliterative bronchiolitis). A matched cohort of 16 patients was formed according to type of procedure, age and follow-up (control) from the remaining 36 patients. Data obtained from a period 6 months before clinical onset of the syndrome showed a significant drop of the opsonic capacity (group obliterative bronchiolitis = 87% +/- 7%; control = 100% +/- 9%; p0.023) and rise of the N-acetyl-D-glucosaminidase (group obliterative bronchiolitis = 7.5 +/- 2 U/L; control = 5.8 +/- 1.8 U/L; p0.04). No correlation was found between the number of infectious events or rejection episodes and the incidence of obliterative bronchiolitis. According to these results, it can be concluded that a decrease in the plasma opsonic capacity and a rise in beta-N-acetylglucosaminidase may be early markers before clinical onset of obliterative bronchiolitis. The nonspecific immune system may therefore play an important role in the development of obliterative bronchiolitis.

Published
1994

17. 384: ECLA vs. ECMO — Impact of Different Extracorporeal Life Support Systems as a Bridge to Lung Transplantation – A Single Center Retrospective Analysis

Author

Li, Y., primary, Strueber, M., additional, Gottlieb, J., additional, Gohrbandt, B., additional, Fischer, S., additional, Meyer, A.L., additional, Kuehn, C., additional, Goerler, A., additional, Hagl, C., additional, Warneke, G., additional, Haverich, A., additional, and Simon, A.R., additional

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results